Last reviewed · How we verify

NCT04907136

Developing and Testing Health Warning Labels on the ENDS Device

Recruiting now NA Last updated 3 April 2026
What this trial tests

NA trial testing Preferred ENDS in Electronic Cigarette Use in 80 participants. Currently enrolling.

Timeline
13 December 2023
Primary endpoint
30 December 2026
30 April 2027

Quick facts

Lead sponsorFlorida International University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment80
Start date13 December 2023
Primary completion30 December 2026
Estimated completion30 April 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida International University

Who can join

Adults 21 to 35, any sex, with Electronic Cigarette Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Electronic Cigarette Use

Currently open trials in the same condition.

Other Florida International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04907136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing